simendan has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biasucci, LM; Conte, C; Cribari, F; D'Aiello, A; Liuzzo, G; Narducci, ML; Pedicino, D; Ruggio, A | 1 |
| Bottio, T; Gerosa, G; Piperata, A | 1 |
2 other study(ies) available for simendan and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Levosimendan for acute right heart failure in COVID-19: another arrow in our quiver?
Topics: Aged; COVID-19; COVID-19 Drug Treatment; Heart Failure; Humans; Male; SARS-CoV-2; Simendan; Systemic Inflammatory Response Syndrome | 2022 |
COVID-19 infection in left ventricular assist device patients.
Topics: Aged; Cardiotonic Agents; COVID-19; Dobutamine; Furosemide; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Simendan; Ventricular Dysfunction, Right | 2020 |